tiprankstipranks
Trending News
More News >
Biogen (BIIB)
NASDAQ:BIIB
US Market
Advertisement

Biogen (BIIB) Ratios

Compare
4,845 Followers

Biogen Ratios

BIIB's free cash flow for Q1 2025 was $0.74. For the 2025 fiscal year, BIIB's free cash flow was decreased by $ and operating cash flow was $0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.44 2.00 2.99 1.83 1.84
Quick Ratio
1.01 1.26 2.58 1.51 1.55
Cash Ratio
0.49 0.31 1.04 0.53 0.36
Solvency Ratio
0.20 0.14 0.32 0.16 0.32
Operating Cash Flow Ratio
0.49 0.45 0.42 0.85 1.13
Short-Term Operating Cash Flow Coverage
1.48 10.31 0.00 3.64 0.00
Net Current Asset Value
$ -3.43B$ -5.19B$ -1.37B$ -5.06B$ -7.05B
Leverage Ratios
Debt-to-Assets Ratio
0.24 0.27 0.27 0.32 0.32
Debt-to-Equity Ratio
0.39 0.50 0.49 0.69 0.73
Debt-to-Capital Ratio
0.28 0.33 0.33 0.41 0.42
Long-Term Debt-to-Capital Ratio
0.21 0.31 0.32 0.36 0.41
Financial Leverage Ratio
1.65 1.81 1.83 2.18 2.30
Debt Service Coverage Ratio
1.22 5.65 15.10 1.94 21.29
Interest Coverage Ratio
9.43 8.49 9.41 11.20 20.45
Debt to Market Cap
0.34 0.19 0.16 0.20 0.19
Interest Debt Per Share
46.97 52.42 47.22 52.70 50.04
Net Debt to EBITDA
1.49 2.65 0.73 2.15 1.13
Profitability Margins
Gross Profit Margin
75.58%74.24%77.61%80.79%86.57%
EBIT Margin
20.31%19.14%37.73%18.20%39.20%
EBITDA Margin
27.53%24.17%42.83%22.64%42.62%
Operating Profit Margin
23.17%21.32%22.81%25.87%33.84%
Pretax Profit Margin
17.85%13.18%35.31%15.89%37.54%
Net Profit Margin
15.07%11.81%29.95%14.17%29.76%
Continuous Operations Profit Margin
15.07%11.81%29.11%15.73%30.20%
Net Income Per EBT
84.42%89.54%84.83%89.16%79.26%
EBT Per EBIT
77.06%61.83%154.81%61.44%110.93%
Return on Assets (ROA)
5.28%4.33%12.41%6.52%16.25%
Return on Equity (ROE)
8.97%7.85%22.76%14.20%37.44%
Return on Capital Employed (ROCE)
10.00%8.96%10.90%14.51%21.80%
Return on Invested Capital (ROIC)
7.84%7.94%8.94%13.33%17.44%
Return on Tangible Assets
12.36%9.47%17.97%9.79%25.36%
Earnings Yield
7.94%3.10%7.57%4.35%10.15%
Efficiency Ratios
Receivables Turnover
4.92 4.68 4.76 5.60 5.78
Payables Turnover
6.12 6.28 4.64 3.58 3.97
Inventory Turnover
1.05 1.00 1.69 1.56 1.69
Fixed Asset Turnover
2.82 2.64 2.75 2.90 3.50
Asset Turnover
0.35 0.37 0.41 0.46 0.55
Working Capital Turnover Ratio
4.61 1.98 2.02 3.28 4.04
Cash Conversion Cycle
360.82 383.96 213.29 197.09 187.27
Days of Sales Outstanding
74.24 77.93 76.65 65.20 63.18
Days of Inventory Outstanding
346.18 364.14 215.38 233.82 216.06
Days of Payables Outstanding
59.60 58.11 78.74 101.94 91.98
Operating Cycle
420.42 442.07 292.03 299.02 279.25
Cash Flow Ratios
Operating Cash Flow Per Share
17.67 10.69 9.53 24.41 26.29
Free Cash Flow Per Share
15.71 8.54 7.85 22.43 22.86
CapEx Per Share
1.96 2.15 1.67 1.98 3.43
Free Cash Flow to Operating Cash Flow
0.89 0.80 0.82 0.92 0.87
Dividend Paid and CapEx Coverage Ratio
9.03 4.97 5.69 12.34 7.67
Capital Expenditure Coverage Ratio
9.03 4.97 5.69 12.34 7.67
Operating Cash Flow Coverage Ratio
0.39 0.21 0.21 0.48 0.54
Operating Cash Flow to Sales Ratio
0.26 0.16 0.14 0.33 0.31
Free Cash Flow Yield
12.29%3.30%2.84%9.35%9.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
12.66 32.25 13.21 22.99 9.85
Price-to-Sales (P/S) Ratio
1.91 3.81 3.96 3.26 2.93
Price-to-Book (P/B) Ratio
1.10 2.53 3.01 3.26 3.69
Price-to-Free Cash Flow (P/FCF) Ratio
8.18 30.30 35.26 10.69 10.71
Price-to-Operating Cash Flow Ratio
7.25 24.20 29.07 9.83 9.31
Price-to-Earnings Growth (PEG) Ratio
-1.34 -0.52 0.13 -0.40 -0.47
Price-to-Fair Value
1.10 2.53 3.01 3.26 3.69
Enterprise Value Multiple
8.44 18.40 9.97 16.54 8.01
Enterprise Value
22.71B 43.73B 43.43B 41.11B 45.89B
EV to EBITDA
8.40 18.40 9.97 16.54 8.01
EV to Sales
2.31 4.45 4.27 3.74 3.41
EV to Free Cash Flow
9.89 35.39 38.06 12.29 12.48
EV to Operating Cash Flow
8.80 28.27 31.37 11.30 10.85
Tangible Book Value Per Share
6.28 1.50 39.84 19.97 11.43
Shareholders’ Equity Per Share
116.21 102.28 92.14 73.51 66.41
Tax and Other Ratios
Effective Tax Rate
0.16 0.10 0.18 0.03 0.20
Revenue Per Share
67.19 67.97 70.02 73.65 83.56
Net Income Per Share
10.13 8.02 20.97 10.44 24.86
Tax Burden
0.84 0.90 0.85 0.89 0.79
Interest Burden
0.88 0.69 0.94 0.87 0.96
Research & Development to Revenue
0.21 0.25 0.22 0.23 0.30
SG&A to Revenue
0.00 0.25 0.23 0.23 0.18
Stock-Based Compensation to Revenue
0.03 0.03 0.02 0.02 0.01
Income Quality
1.75 1.33 0.47 2.11 1.04
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis